19,99 €
inkl. MwSt.
Versandfertig in 6-10 Tagen
10 °P sammeln
Andere Kunden interessierten sich auch für
![MAGNETIC RESONANCE IMAGING IN RECTAL CANCER]( "MAGNETIC RESONANCE IMAGING IN RECTAL CANCER")
MAGNETIC RESONANCE IMAGING IN RECTAL CANCER26,99 €![Neo adjvant chemo radiation in locally advanced rectal cancer patients]( "Neo adjvant chemo radiation in locally advanced rectal cancer patients")
Neo adjvant chemo radiation in locally advanced rectal cancer patients36,99 €![miRNA expression profiling in locally advanced rectal cancer]( "miRNA expression profiling in locally advanced rectal cancer")
miRNA expression profiling in locally advanced rectal cancer19,99 €![Predictors in rectal cancer patients]( "Predictors in rectal cancer patients")
Predictors in rectal cancer patients32,99 €![Impact of neoadjuvant therapy in downstaging low rectal adenocarcinoma]( "Impact of neoadjuvant therapy in downstaging low rectal adenocarcinoma")
Impact of neoadjuvant therapy in downstaging low rectal adenocarcinoma16,99 €![Injection sclerotherapy for adult complete rectal prolapse]( "Injection sclerotherapy for adult complete rectal prolapse")
Injection sclerotherapy for adult complete rectal prolapse38,99 €![Rectal cancer; Dynamics of the tumor VEGF and the density of CD8+ TIL]( "Rectal cancer; Dynamics of the tumor VEGF and the density of CD8+ TIL")
Rectal cancer; Dynamics of the tumor VEGF and the density of CD8+ TIL19,99 €
Malignant tumors of the colon and rectum are the most common cancers in developed countries. The incidence of rectal adenocarcinoma represents approximately 30% of this number. A neoadjuvant chemoradiotherapy followed by total mesorectal excision is the current standard of the treatment in patients with locally advanced rectal adenocarcinoma.The aim of this retrospective study was to determine the prognostic impact of EGFR expression changes during neoadjuvant chemoradiotherapy in patients with locally advanced rectal cancer.